Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
spädningsvätska för parenteral användning
DRUG
2 trials
Sponsors
Rigshospitalet, Rigshospitalet
, Lipigon Pharmaceuticals AB
Conditions
Moderate to severe hypertriglyceridemia
Trigeminal neuralgia
Phase 2
A phase 2, randomised, double-blind, placebo-controlled trial to evaluate safety and local tolerability of four weekly administrations of A24110He in subjects with elevated triglyceride plasma concentrations
Completed
CTIS2023-509091-42-00
Lipigon Pharmaceuticals AB
Moderate to severe hypertriglyceridemia
Start: 2024-02-27
End: 2026-01-08
Target: 26
Updated: 2025-07-04
Phase 3
Safety and efficacy of botulinum toxin A in patients with trigeminal neuralgia: a double-blind, randomized, placebo-controlled, parallel-group trial and investigation of neuro-inflammatory biomarkers as predictors of efficacy
Recruiting
CTIS2023-504567-17-00
Rigshospitalet, Rigshospitalet
Trigeminal neuralgia
Start: 2023-11-15
Target: 80
Updated: 2025-08-14